Accretion Pharmaceuticals Ltd

Accretion Pharmaceuticals Ltd IPO

IPO Price Range: ₹96 - 101

Presently our Company is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), And Oral Powder (Sachet, Dry Syrup) etc.

Min Investment

₹1,21,200

IPO Size

₹29 Cr

IPO Status

Live

Quantity in 1 Lot

1200

Max Bid allowed

1

Listing Exchange

NSE

IPO Application Timeline of Accretion Pharmaceuticals Ltd

upcoming
Open Date14 May 2025
Close Date16 May 2025
Allotment Date19 May 2025
Listing Date21 May 2025

Key Statistics

Bid Opening DateBid Opening Date14 May 2025
Bid Closing DateBid Closing Date16 May 2025
Allotment DateAllotment Date19 May 2025
Issue SizeIssue Size₹29.75Cr
Quantity in 1 lotQuantity in 1 lot1200

Strengths and Risks of Accretion Pharmaceuticals Ltd IPO

Strengths

Strengths

  • Experienced Promoters and Management Team.

  • Consistently supplying quality products to our valued customers in time.

  • Continually improving the quality standards by implementing process control and prevention techniques.

  • Long-standing relationship with clients and suppliers.

  • Quality standards.

  • Legacy Business Process & Management.

  • Strong and experienced R&D team.


Risks

Risks

  • A significant portion of its revenue is derived from exports, and any decline in exportprofitability may adversely impact its overall financial performance.

  • The Company operates in pharmaceutical sector, which is extensively regulated, any failures onthe company part to comply with the existing and future statutory and/or regulatory requirements in the pharmaceutical sector could adversely affect its business, results of operations and financialcondition.

  • Its manufacturing units are subject to periodic inspections and audits by regulatory authoritiesand clients. Its may be subject to regulatory action which may damage the company reputation leading to an adverse effect on its business, results of operations, financial condition and cash flows.

  • The company has a very limited operating history as a Company, which may make it difficult for investors to evaluate its historical performance or future prospects.

  • The company has only one Manufacturing Facility, continued operations of its manufacturing facility is critical to the company business and any disruption in the operation of its manufacturing facility may have a material adverse effect on the company business, results of operations and financial condition.

  • The company generate a significant percentage of its revenue from few clients. The loss of any one or more of the company major clients would have a material adverse effect on its business operations and profitability.

  • Its inability to accurately forecast demand for the company products or manage its inventory or working capital requirements may have an adverse effect on the company business, results of operations and financial condition.

  • There was a Criminal litigation against its promoters cum directors and the company is not sure the same shall not be refiled by the concerned authority. In the event it is refiled, the interest of the promoters may divert from the business of the Company, which may adversely affect the business of the Company.

  • Its business operations are working capital intensive, and any inability to meet the company working capital requirements may adversely impact its financial condition and growth prospects.

  • The company has certain outstanding litigation against it, an adverse outcome of which may adversely affect its business, reputation and results of operations.

Promoters Holding

Investors Holdings %
Harshad Nanubhai Rathod24.07%
Vivek Ashok Kumar Patel24.07%
Mayur Popatlal Sojitra24.07%
Hardik Mukundbhai Prajapati24.07%
Ankita Vivek Patel0.93%

Frequently Asked Questions of Accretion Pharmaceuticals Ltd IPO

  • What is the size of the Accretion Pharmaceuticals Ltd IPO?

    The size of the Accretion Pharmaceuticals Ltd IPO is ₹29.75Cr .

  • What is 'pre-apply' for Accretion Pharmaceuticals Ltd IPO?

    'Pre-apply' for Accretion Pharmaceuticals Ltd IPO indicates your interest in the IPO before it opens for subscription. This ensures quick application when the IPO goes live.

  • When will my Accretion Pharmaceuticals Ltd IPO order be placed?

    Your Accretion Pharmaceuticals Ltd IPO order will be placed on 14 May 2025.

  • What are the open and close dates of the Accretion Pharmaceuticals Ltd IPO?

    The open and close dates of the Accretion Pharmaceuticals Ltd IPO are 14 May 2025 to 16 May 2025.

  • What is the lot size and minimum order quantity of the Accretion Pharmaceuticals Ltd IPO?

    The lot size and minimum order quantity of the Accretion Pharmaceuticals Ltd IPO are 1200 and 1200 respectively.

  • What would be the listing gains on the Accretion Pharmaceuticals Ltd IPO?

    The potential listing gains on the Accretion Pharmaceuticals Ltd IPO will depend on various market factors and cannot be predicted with certainty.